ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,286.48
0.13%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,326.96
0.05%
Brent Oil
81.235
0.53%
Bitcoin
69,060.58
1.94%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Kiniksa Pharmaceuticals Ltd (KNSA) Share Price

KNSA Kiniksa Pharmaceuticals Ltd

19.01
0.00 (0.00%)
Pre Market
Last Updated: 09:00:00
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Kiniksa Pharmaceuticals Ltd NASDAQ:KNSA NASDAQ Common Stock  Class A Common Stock
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.00 0.00 19.01 17.49 19.65 0.00 0.00   08:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 270.26M 14.08M 0.1994 95.34 1.34B
 Type  Size  Price  Time  Units 
   0.00  
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore KNSA News
29/05/202422:19EDGAR2Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
07/05/202421:01GLOBEKiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference
23/04/202412:30GLOBEKiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution
16/04/202421:01GLOBEKiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024
02/04/202412:30GLOBEKiniksa Pharmaceuticals Announces Development Indication for Abiprubart
05/03/202421:34EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
05/03/202421:31EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
Period
Draw mode
Data Downloads for KNSA

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Kiniksa Pharmaceuticals Ltd Articles